216 related articles for article (PubMed ID: 23817618)
1. Role of the zinc uptake ABC transporter of Moraxella catarrhalis in persistence in the respiratory tract.
Murphy TF; Brauer AL; Kirkham C; Johnson A; Koszelak-Rosenblum M; Malkowski MG
Infect Immun; 2013 Sep; 81(9):3406-13. PubMed ID: 23817618
[TBL] [Abstract][Full Text] [Related]
2. ATP-Binding Cassette (ABC) Transporters of the Human Respiratory Tract Pathogen, Moraxella catarrhalis: Role in Virulence.
Murphy TF; Brauer AL; Johnson A; Kirkham C
PLoS One; 2016; 11(7):e0158689. PubMed ID: 27391026
[TBL] [Abstract][Full Text] [Related]
3. Role of the oligopeptide permease ABC Transporter of Moraxella catarrhalis in nutrient acquisition and persistence in the respiratory tract.
Jones MM; Johnson A; Koszelak-Rosenblum M; Kirkham C; Brauer AL; Malkowski MG; Murphy TF
Infect Immun; 2014 Nov; 82(11):4758-66. PubMed ID: 25156736
[TBL] [Abstract][Full Text] [Related]
4. Substrate binding protein SBP2 of a putative ABC transporter as a novel vaccine antigen of Moraxella catarrhalis.
Otsuka T; Kirkham C; Johnson A; Jones MM; Murphy TF
Infect Immun; 2014 Aug; 82(8):3503-12. PubMed ID: 24914218
[TBL] [Abstract][Full Text] [Related]
5. Sulfate-binding protein, CysP, is a candidate vaccine antigen of Moraxella catarrhalis.
Murphy TF; Kirkham C; Johnson A; Brauer AL; Koszelak-Rosenblum M; Malkowski MG
Vaccine; 2016 Jul; 34(33):3855-61. PubMed ID: 27265455
[TBL] [Abstract][Full Text] [Related]
6. Persistence of Moraxella catarrhalis in Chronic Obstructive Pulmonary Disease and Regulation of the Hag/MID Adhesin.
Murphy TF; Brauer AL; Pettigrew MM; LaFontaine ER; Tettelin H
J Infect Dis; 2019 Apr; 219(9):1448-1455. PubMed ID: 30496439
[TBL] [Abstract][Full Text] [Related]
7. The Vaccine Candidate Substrate Binding Protein SBP2 Plays a Key Role in Arginine Uptake, Which Is Required for Growth of Moraxella catarrhalis.
Otsuka T; Kirkham C; Brauer A; Koszelak-Rosenblum M; Malkowski MG; Murphy TF
Infect Immun; 2016 Feb; 84(2):432-8. PubMed ID: 26597985
[TBL] [Abstract][Full Text] [Related]
8. Virulence determinants of Moraxella catarrhalis: distribution and considerations for vaccine development.
Blakeway LV; Tan A; Peak IRA; Seib KL
Microbiology (Reading); 2017 Oct; 163(10):1371-1384. PubMed ID: 28893369
[TBL] [Abstract][Full Text] [Related]
9. Identification of a conserved Moraxella catarrhalis haemoglobin-utilization protein, MhuA.
Furano K; Luke NR; Howlett AJ; Campagnari AA
Microbiology (Reading); 2005 Apr; 151(Pt 4):1151-1158. PubMed ID: 15817782
[TBL] [Abstract][Full Text] [Related]
10. The Respiratory Pathogen Moraxella catarrhalis Targets Collagen for Maximal Adherence to Host Tissues.
Singh B; Alvarado-Kristensson M; Johansson M; Hallgren O; Westergren-Thorsson G; Mörgelin M; Riesbeck K
mBio; 2016 Mar; 7(2):e00066. PubMed ID: 27006460
[TBL] [Abstract][Full Text] [Related]
11. A Cation-Binding Surface Protein as a Vaccine Antigen To Prevent Moraxella catarrhalis Otitis Media and Infections in Chronic Obstructive Pulmonary Disease.
Murphy TF; Brauer AL; Johnson A; Wilding GE; Koszelak-Rosenblum M; Malkowski MG
Clin Vaccine Immunol; 2017 Sep; 24(9):. PubMed ID: 28659326
[No Abstract] [Full Text] [Related]
12. Characterization of the molecular interplay between Moraxella catarrhalis and human respiratory tract epithelial cells.
de Vries SP; Eleveld MJ; Hermans PW; Bootsma HJ
PLoS One; 2013; 8(8):e72193. PubMed ID: 23936538
[TBL] [Abstract][Full Text] [Related]
13. Characterization of proteins Msp22 and Msp75 as vaccine antigens of Moraxella catarrhalis.
Ruckdeschel EA; Brauer AL; Johnson A; Murphy TF
Vaccine; 2009 Nov; 27(50):7065-72. PubMed ID: 19786139
[TBL] [Abstract][Full Text] [Related]
14. Characterization and evaluation of the Moraxella catarrhalis oligopeptide permease A as a mucosal vaccine antigen.
Yang M; Johnson A; Murphy TF
Infect Immun; 2011 Feb; 79(2):846-57. PubMed ID: 21134967
[TBL] [Abstract][Full Text] [Related]
15. Moraxella catarrhalis uses a twin-arginine translocation system to secrete the β-lactamase BRO-2.
Balder R; Shaffer TL; Lafontaine ER
BMC Microbiol; 2013 Jun; 13():140. PubMed ID: 23782650
[TBL] [Abstract][Full Text] [Related]
16. A Moraxella catarrhalis vaccine to protect against otitis media and exacerbations of COPD: An update on current progress and challenges.
Perez AC; Murphy TF
Hum Vaccin Immunother; 2017 Oct; 13(10):2322-2331. PubMed ID: 28853985
[TBL] [Abstract][Full Text] [Related]
17. Sputum
George LM; Haigh RD; Mistry V; Haldar K; Barer MR; Oggioni MR; Brightling CE
Int J Chron Obstruct Pulmon Dis; 2018; 13():3663-3667. PubMed ID: 30510409
[TBL] [Abstract][Full Text] [Related]
18. Respiratory tract carrier rates of Moraxella (Branhamella) catarrhalis in adults and children and interpretation of the isolation of M. catarrhalis from sputum.
Vaneechoutte M; Verschraegen G; Claeys G; Weise B; Van den Abeele AM
J Clin Microbiol; 1990 Dec; 28(12):2674-80. PubMed ID: 2126266
[TBL] [Abstract][Full Text] [Related]
19. Moraxella catarrhalis M35 is a general porin that is important for growth under nutrient-limiting conditions and in the nasopharynges of mice.
Easton DM; Maier E; Benz R; Foxwell AR; Cripps AW; Kyd JM
J Bacteriol; 2008 Dec; 190(24):7994-8002. PubMed ID: 18931134
[TBL] [Abstract][Full Text] [Related]
20. Moraxella catarrhalis induces an immune response in the murine lung that is independent of human CEACAM5 expression and long-term smoke exposure.
Gutbier B; Fischer K; Doehn JM; von Lachner C; Herr C; Klaile E; Frischmann U; Singer BB; Riesbeck K; Zimmermann W; Suttorp N; Bachmann S; Bals R; Witzenrath M; Slevogt H
Am J Physiol Lung Cell Mol Physiol; 2015 Aug; 309(3):L250-61. PubMed ID: 26047639
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
